NeuroPace, Inc. NPCE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 98.84M | 95.51M | 91.76M | 86.64M | 80.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 98.84M | 95.51M | 91.76M | 86.64M | 80.35M |
| Cost of Revenue | 20.14M | 19.50M | 18.67M | 17.94M | 17.40M |
| Gross Profit | 78.70M | 76.01M | 73.09M | 68.70M | 62.95M |
| SG&A Expenses | 66.09M | 66.49M | 64.52M | 62.99M | 59.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 113.91M | 113.64M | 111.08M | 107.84M | 103.19M |
| Operating Income | -15.08M | -18.12M | -19.32M | -21.20M | -22.85M |
| Income Before Tax | -19.11M | -22.93M | -24.44M | -26.96M | -28.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -19.11 | -22.93 | -24.44 | -26.96 | -28.92 |
| Earnings from Discontinued Operations | -- | 1.37M | 2.98M | 2.98M | 2.98M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.11M | -21.57M | -21.47M | -23.99M | -25.94M |
| EBIT | -15.08M | -18.12M | -19.32M | -21.20M | -22.85M |
| EBITDA | -14.82M | -17.88M | -19.08M | -21.00M | -22.64M |
| EPS Basic | -0.57 | -0.65 | -0.66 | -0.75 | -0.83 |
| Normalized Basic EPS | -0.36 | -0.42 | -0.47 | -0.53 | -0.58 |
| EPS Diluted | -0.57 | -0.65 | -0.66 | -0.75 | -0.83 |
| Normalized Diluted EPS | -0.36 | -0.42 | -0.47 | -0.53 | -0.58 |
| Average Basic Shares Outstanding | 134.34M | 133.10M | 130.87M | 127.40M | 123.71M |
| Average Diluted Shares Outstanding | 134.34M | 133.10M | 130.87M | 127.40M | 123.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |